REGENXBIO Ownership 2024 | Who Owns REGENXBIO Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

20.34%

Insider Ownership

7.41%

Retail Ownership

72.25%

Institutional Holders

86.00

REGENXBIO Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.18.83%0.00%8,609,3381,010,09613.29%100,729,254Jun 30, 2024
VANGUARD GROUP INC11.18%0.00%5,113,782236,9014.86%59,831,249Jun 30, 2024
REDMILE GROUP, LLC9.99%3.23%4,569,80218,2460.40%53,466,683Jun 30, 2024
JPMORGAN CHASE & CO6.59%0.00%3,012,476-710,077-19.07%35,245,970Jun 30, 2024
STATE STREET CORP6.28%0.00%2,873,235-249,404-7.99%33,616,850,000Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP2.84%0.65%1,300,064--15,210,749Jun 30, 2024
MORGAN STANLEY2.58%0.00%1,179,852-159,986-11.94%13,804,272Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP2.42%0.00%1,107,453-89,620-7.49%12,957,117Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.28%0.00%1,044,61494,0639.90%12,224,476Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC2.08%1.06%950,000190,00025.00%11,115,000Jun 30, 2024
AQUILO CAPITAL MANAGEMENT, LLC1.98%10.22%906,248--10,603,102Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.1.79%0.02%816,384588,773258.68%9,551,693Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.1.76%0.02%806,715379,76088.95%9,438,566Jun 30, 2024
GOLDMAN SACHS GROUP INC1.42%0.00%649,243-74,362-10.28%7,596,143Jun 30, 2024
BIOIMPACT CAPITAL LLC1.22%1.01%557,0767,9981.46%6,517,789Jun 30, 2024
SONIC GP LLC0.99%10.94%453,079-90,000-16.57%5,301,024Jun 30, 2024
NORTHERN TRUST CORP0.95%0.00%432,2504650.11%5,057,326,000Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.83%0.00%380,68437,06910.79%4,454,003Jun 30, 2024
WS MANAGEMENT LLLP0.83%0.33%379,059--4,434,990Jun 30, 2024
RTW INVESTMENTS, LP0.77%0.06%350,000--4,095,000Jun 30, 2024

REGENXBIO's largest institutional shareholder is BLACKROCK INC., holding 18.83% of the company's total share outstanding, currently valued at $100.73M. The top 10 institutional shareholders own together 65.07% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SONIC GP LLC0.99%10.94%453,079-90,000-16.57%5,301,024Jun 30, 2024
AQUILO CAPITAL MANAGEMENT, LLC1.98%10.22%906,248--10,603,102Jun 30, 2024
REDMILE GROUP, LLC9.99%3.23%4,569,80218,2460.40%53,466,683Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC2.08%1.06%950,000190,00025.00%11,115,000Jun 30, 2024
BIOIMPACT CAPITAL LLC1.22%1.01%557,0767,9981.46%6,517,789Jun 30, 2024
ARCHPOINT INVESTORS0.49%0.99%224,278--2,624,053Jun 30, 2024
LION POINT CAPITAL, LP0.08%0.77%36,2503,75011.54%424,125Jun 30, 2024
AVIDITY PARTNERS MANAGEMENT LP2.84%0.65%1,300,064--15,210,749Jun 30, 2024
GHOST TREE CAPITAL, LLC0.37%0.62%170,00050,00041.67%1,989,000Jun 30, 2024
NAPATREE CAPITAL LLC0.11%0.47%49,7644,1769.16%582,239Jun 30, 2024
WS MANAGEMENT LLLP0.83%0.33%379,059--4,434,990Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.33%0.12%151,753151,753100.00%1,776,000Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC0.03%0.12%13,360--156,312Jun 30, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.29%0.08%134,19027,90626.26%1,570,023Jun 30, 2024
ARTAL GROUP S.A.0.55%0.07%250,000--2,925,000Jun 30, 2024
QUEST PARTNERS LLC0.09%0.07%42,00041,64511730.99%491,400Jun 30, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD0.11%0.06%48,95432,002188.78%573,000Jun 30, 2024
RTW INVESTMENTS, LP0.77%0.06%350,000--4,095,000Jun 30, 2024
WINTON GROUP LTD0.17%0.06%76,84034,13679.94%899,028Jun 30, 2024
XTX TOPCO LTD0.12%0.05%52,65139,358296.08%616,017Jun 30, 2024

The largest REGENXBIO shareholder by % of total assets is SONIC GP LLC. The company owns 453.08K shares of REGENXBIO (RGNX), representing 10.94% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.18.83%0.00%8,609,3381,010,09613.29%100,729,254Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.1.79%0.02%816,384588,773258.68%9,551,693Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.1.76%0.02%806,715379,76088.95%9,438,566Jun 30, 2024
VANGUARD GROUP INC11.18%0.00%5,113,782236,9014.86%59,831,249Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC2.08%1.06%950,000190,00025.00%11,115,000Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.33%0.12%151,753151,753100.00%1,776,000Jun 30, 2024
NORGES BANK0.32%0.00%147,546147,546100.00%1,726,288Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.67%0.00%306,487140,66684.83%3,585,898Jun 30, 2024
SQUAREPOINT OPS LLC0.32%0.00%146,259126,249630.93%1,711,230Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.36%0.01%165,000120,100267.48%1,930,500Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.24%0.00%109,725109,725100.00%1,283,511Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.28%0.00%1,044,61494,0639.90%12,224,476Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH0.20%0.00%92,60092,600100.00%1,083,420Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.39%0.00%179,74089,75699.75%2,102,958Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.41%0.01%188,23579,65573.36%2,202,355Jun 30, 2024
JUMP FINANCIAL, LLC0.16%0.02%72,97572,975100.00%853,807Jun 30, 2024
UBS OCONNOR LLC0.15%0.05%70,19970,199100.00%821,328Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.24%0.00%109,98267,010155.94%1,286,789Jun 30, 2024
WALLEYE CAPITAL LLC0.12%0.00%55,57655,576100.00%650,239Jun 30, 2024
GHOST TREE CAPITAL, LLC0.37%0.62%170,00050,00041.67%1,989,000Jun 30, 2024

As of Jun 30 2024, REGENXBIO's largest institutional buyer is BLACKROCK INC.. The company purchased 1.01M stocks of RGNX, valued at $100.73M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JPMORGAN CHASE & CO6.59%0.00%3,012,476-710,077-19.07%35,245,970Jun 30, 2024
STATE STREET CORP6.28%0.00%2,873,235-249,404-7.99%33,616,850,000Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.00%0.00%1,471-168,747-99.14%17,108Jun 30, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.----165,073-100.00%-Jun 30, 2024
MORGAN STANLEY2.58%0.00%1,179,852-159,986-11.94%13,804,272Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.17%0.00%78,436-157,526-66.76%917,701Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.33%0.01%152,437-139,904-47.86%1,783,513Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.11%0.00%49,120-134,675-73.27%574,702Jun 30, 2024
PANAGORA ASSET MANAGEMENT INC0.41%0.01%185,755-114,359-38.11%2,173,334Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----110,000-100.00%-Jun 30, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC----103,065-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----97,500-100.00%-Jun 30, 2024
SONIC GP LLC0.99%10.94%453,079-90,000-16.57%5,301,024Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP2.42%0.00%1,107,453-89,620-7.49%12,957,117Jun 30, 2024
EXOME ASSET MANAGEMENT LLC----84,470-100.00%-Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.23%0.00%103,190-76,678-42.63%1,207,323Jun 30, 2024
GOLDMAN SACHS GROUP INC1.42%0.00%649,243-74,362-10.28%7,596,143Jun 30, 2024
BNP PARIBAS ARBITRAGE, SNC0.01%-2,908-48,568-94.35%34,024Jun 30, 2024
LIBERTY ONE INVESTMENT MANAGEMENT, LLC----48,060-100.00%-Jun 30, 2024
WOODLINE PARTNERS LP0.22%0.01%100,000-46,334-31.66%1,170,000Jun 30, 2024

As of Jun 30 2024, REGENXBIO's biggest institutional seller is JPMORGAN CHASE & CO. The company sold -0.71M shares of RGNX, valued at $35.25M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GSA CAPITAL PARTNERS LLP0.33%0.12%151,753151,753100.00%1,776,000Jun 30, 2024
NORGES BANK0.32%0.00%147,546147,546100.00%1,726,288Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.24%0.00%109,725109,725100.00%1,283,511Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH0.20%0.00%92,60092,600100.00%1,083,420Jun 30, 2024
UBS OCONNOR LLC0.15%0.05%70,19970,199100.00%821,328Jun 30, 2024
WALLEYE CAPITAL LLC0.12%0.00%55,57655,576100.00%650,239Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC0.09%0.00%42,29242,292100.00%494,000Jun 30, 2024
MARSHALL WACE, LLP0.09%0.00%39,09339,093100.00%457,388Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD0.08%0.02%38,84438,844100.00%454,475Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.06%0.00%26,67426,674100.00%312,086Jun 30, 2024
TUDOR INVESTMENT CORP ET AL0.06%0.00%26,40726,407100.00%308,962Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.03%0.03%15,85715,857100.00%185,527Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP0.03%0.00%15,22215,222100.00%178,097Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.0.03%0.00%12,37512,375100.00%144,788Jun 30, 2024
DIVERSIFIED TRUST CO0.02%0.00%10,35210,352100.00%121,118Jun 30, 2024
SIMPLEX TRADING, LLC0.01%-5,2555,255100.00%61,000Jun 30, 2024
AQUATIC CAPITAL MANAGEMENT LLC0.01%0.00%2,6002,600100.00%30,420Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.01%1,2001,200100.00%14,040Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%9797100.00%1,128Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%-2323100.00%270Jun 30, 2024
INNEALTA CAPITAL, LLC--88100.00%94Jun 30, 2024
LARSON FINANCIAL GROUP LLC--44100.00%47Jun 30, 2024

REGENXBIO's largest new institutional shareholder by number of shares is GSA CAPITAL PARTNERS LLP, purchased 151.75K shares, valued at $1.78M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAGE CAPITAL PARTNERS GP, L.L.C.----165,073-100.00%-Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC----110,000-100.00%-Jun 30, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC----103,065-100.00%-Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC----97,500-100.00%-Jun 30, 2024
EXOME ASSET MANAGEMENT LLC----84,470-100.00%-Jun 30, 2024
LIBERTY ONE INVESTMENT MANAGEMENT, LLC----48,060-100.00%-Jun 30, 2024
OVATA CAPITAL MANAGEMENT LTD----40,000-100.00%-Jun 30, 2024
RESOLUTE CAPITAL ASSET PARTNERS LLC----40,000-100.00%-Jun 30, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC----34,041-100.00%-Jun 30, 2024
BARCLAYS PLC----25,000-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----22,744-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----22,128-100.00%-Jun 30, 2024
PRELUDE CAPITAL MANAGEMENT, LLC----21,565-100.00%-Jun 30, 2024
CRESSET ASSET MANAGEMENT, LLC----17,731-100.00%-Jun 30, 2024
DARK FOREST CAPITAL MANAGEMENT LP----12,984-100.00%-Jun 30, 2024
BELLEVUE GROUP AG----12,000-100.00%-Jun 30, 2024
PROSHARE ADVISORS LLC----11,384-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----2,284-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----2,100-100.00%-Jun 30, 2024
KBC GROUP NV----1,801-100.00%-Jun 30, 2024
LAZARD ASSET MANAGEMENT LLC----1,771-100.00%-Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.----1,600-100.00%-Jun 30, 2024
QUARRY LP----1,200-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----928-100.00%-Jun 30, 2024
WR WEALTH PLANNERS, LLC----192-100.00%-Jun 30, 2024
IFP ADVISORS, INC----125-100.00%-Jun 30, 2024
RIGGS ASSET MANAGMENT CO. INC.----34-100.00%-Jun 30, 2024
PRIVATE WEALTH MANAGEMENT GROUP, LLC----27-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----8-100.00%-Jun 30, 2024
ROTHSCHILD INVESTMENT LLC----5-100.00%-Jun 30, 2024

REGENXBIO's largest sold out institutional shareholder by shares sold is ADAGE CAPITAL PARTNERS GP, L.L.C., sold -0.17M shares, valued at -, as of undefined.

REGENXBIO Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SPARROW FUNDS2.16%7,685--Feb 29, 2024
HARTFORD HLS SERIES FUND II INC0.40%97,714--Dec 31, 2023
Vanguard Montgomery Funds0.28%66,53341,092161.52%Mar 31, 2024
ROYCE VALUE TRUST, INC.0.18%149,664--Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS IV0.13%149,000--Mar 28, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.06%39,1192,1175.72%Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.06%29,439--Mar 31, 2024
Voya VARIABLE PRODUCTS TRUST0.06%21,975--Mar 31, 2024
VANGUARD ADMIRAL FUNDS0.06%246,21534,66616.39%Feb 29, 2024
VANGUARD VALLEY FORGE FUNDS0.06%28,991--Mar 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.05%9,532-12,199-56.14%Mar 28, 2024
SYNTAX ETF TRUST0.05%1,54320014.89%Mar 31, 2024
TEKLA HEALTHCARE INVESTORS0.04%37,858--Mar 31, 2024
BNY MELLON INDEX FUNDS, INC.0.04%40,831-6,007-12.83%Jan 31, 2024
TOCQUEVILLE TRUST0.04%5,000--Jan 31, 2024
BRIDGEWAY FUNDS INC0.04%84,900--Mar 28, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.03%20,0421810.91%Mar 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.03%108,057--Mar 31, 2024
Vericimetry Funds0.02%2,122--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.02%82,807--Jan 31, 2024
Voya EQUITY TRUST0.02%30,301--Feb 29, 2024
Humankind Benefit Corp0.02%444-36-7.50%Dec 31, 2023
PFM Multi-Manager Series Trust0.02%13,0108366.87%Dec 31, 2023
FRANKLIN STRATEGIC SERIES0.01%123,076--Jan 31, 2024
ALGER FUNDS0.01%13,000--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%74,435--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,270--Mar 31, 2024
Tekla Healthcare Opportunities Fund0.01%21,700--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%30,6064961.65%Feb 29, 2024
VANGUARD INDEX FUNDS0.01%3,744,204-250,978-6.28%Mar 31, 2024
IndexIQ ETF Trust0.01%17,200-1,208-6.56%Jan 31, 2024
EXCHANGE TRADED CONCEPTS TRUST0.01%33,886--Feb 29, 2024
RANGER FUNDS INVESTMENT TRUST0.01%211211-Apr 30, 2020
Harbor ETF Trust0.01%25,440-2,643-9.41%Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%1,062--Mar 31, 2024
JNL VARIABLE FUND LLC0.00%24,943--Mar 31, 2020
T. Rowe Price Equity Series, Inc.0.00%5,047--Mar 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.00%6,877--Mar 31, 2024
Fidelity Commonwealth Trust II0.00%19,724--Aug 31, 2023
ETFis Series Trust I0.00%3,942-1,083-21.55%Jan 31, 2024
SCHWAB CAPITAL TRUST0.00%111,771580.05%Jan 31, 2024
UBS FUNDS0.00%11,996--Mar 31, 2024
ALPS ETF Trust0.00%28,834--Feb 29, 2024
SSGA FUNDS0.00%898--Feb 29, 2024
VANGUARD EXPLORER FUND0.00%24,655--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%391,2547,5791.98%Feb 29, 2024
TARGET PORTFOLIO TRUST0.00%38,800--Jan 31, 2024
VANGUARD TAX-MANAGED FUNDS0.00%310,539-5,663-1.79%Mar 31, 2024
VANGUARD HORIZON FUNDS0.00%35,36324,135214.95%Mar 31, 2024
Calvert Variable Products, Inc.0.00%4,037--Mar 31, 2024
Legg Mason ETF Investment Trust0.00%2,671--Mar 31, 2024
JPMORGAN TRUST II0.00%1,323,438--Feb 29, 2024
VALIC Co II0.00%44,9959,42326.49%Feb 28, 2021
SHELTON FUNDS0.00%1,997--Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%20,208-321-1.56%Jan 31, 2024
STEWARD FUNDS, INC.0.00%2,560--Jan 31, 2024
PRAXIS MUTUAL FUNDS0.00%11,450--Dec 31, 2023
HARBOR FUNDS0.00%23,557-1,600-6.36%Jan 31, 2024
OHIO NATIONAL FUND INC0.00%18,237--Mar 31, 2024
ProFunds0.00%10,5942,22126.53%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%27,4282,85511.62%Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%8,400--Mar 28, 2024
TIMOTHY PLAN0.00%4,019--Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%837,212254,26343.62%Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%25,674-19,794-43.53%Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%25,192--Mar 31, 2024
Dimensional ETF Trust0.00%341,9204,8011.42%Jan 31, 2024
Direxion Shares ETF Trust0.00%116,01212,43512.01%Jan 31, 2024
VALIC Co I0.00%200,895-22,265-9.98%Feb 29, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%2,564--Mar 31, 2024
VANGUARD WORLD FUND0.00%146,2665,5513.94%Feb 29, 2024
GPS Funds I0.00%2,910--Mar 31, 2024
PRUDENTIAL SERIES FUND0.00%42,218-1,050-2.43%Mar 28, 2024
SunAmerica Specialty Series0.00%281--Apr 30, 2021
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%28,703-1,462-4.85%Dec 31, 2023
Principal Exchange-Traded Funds0.00%5,998-18,988-75.99%Mar 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%78,041--Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%53,45512,31429.93%Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%36,463-73,075-66.71%Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,970--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%9,0152242.55%Mar 31, 2024
Global X Funds0.00%17,074-54,370-76.10%Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%210,6927,3073.59%Feb 29, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%257-17-6.20%Sep 30, 2023
THRIVENT SERIES FUND INC0.00%35,111-953-2.64%Mar 28, 2024
ROYCE FUND0.00%2,000--Mar 31, 2024
iSHARES TRUST0.00%4,960,707-72,979-1.45%Mar 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%4,806--Mar 31, 2024
Guggenheim Variable Funds Trust0.00%1,091--Dec 31, 2023
Invesco Exchange-Traded Fund Trust II0.00%79,783-10,031-11.17%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%696--Mar 31, 2024
BMO FUNDS, INC.0.00%12,142-162-1.32%Aug 31, 2020
Managed Portfolio Series0.00%5,601--Mar 31, 2024
NORTHERN FUNDS0.00%34,428-3,675-9.64%Mar 28, 2024
KP Funds0.00%10,569-1,000-8.64%Sep 30, 2020
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%14,500-4,700-24.48%Mar 31, 2024
JPMorgan Trust I0.00%248,212--Jan 31, 2024
AMG FUNDS III0.00%1,100--Mar 28, 2024
MASTER INVESTMENT PORTFOLIO0.00%19,225-4,079-17.50%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,3451587.22%Mar 31, 2024

REGENXBIO's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 7.68K shares, compromising 2.16% of its total assets.

REGENXBIO Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2486-55.21%
31 Mar, 2419210.98%
31 Dec, 231736.79%
30 Sep, 23162-5.81%
30 Jun, 23172-2.27%
31 Mar, 23176-4.35%
31 Dec, 22184-0.54%
30 Sep, 2218510.12%
30 Jun, 22168-12.04%
31 Mar, 221917.30%
31 Dec, 21178-6.81%
30 Sep, 211916.70%
30 Jun, 21179-6.28%
31 Mar, 21191-1.55%
31 Dec, 2019414.79%
30 Sep, 20169-8.15%
30 Jun, 201845.75%
31 Mar, 20174-9.84%
31 Dec, 1919310.29%
30 Sep, 19175-9.79%
30 Jun, 19194-10.60%
31 Mar, 1921714.21%
31 Dec, 18190-10.38%
30 Sep, 1821213.37%
30 Jun, 1818746.09%
31 Mar, 1812814.29%
31 Dec, 1711220.43%
30 Sep, 17935.68%
30 Jun, 17882.33%
31 Mar, 178610.26%
31 Dec, 16789.86%
30 Sep, 16711.43%
30 Jun, 167011.11%
31 Mar, 1663-5.97%
31 Dec, 156739.58%
30 Sep, 1548-

As of 30 Jun 24, 86 institutions are holding REGENXBIO's shares, representing a decrease of -55.21% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 249,301,065-78.04%
31 Mar, 2442,349,93811.14%
31 Dec, 2338,105,9423.29%
30 Sep, 2336,891,9200.15%
30 Jun, 2336,837,255-0.58%
31 Mar, 2337,051,8143.93%
31 Dec, 2235,651,1961.71%
30 Sep, 2235,050,281-3.23%
30 Jun, 2236,218,7113.72%
31 Mar, 2234,918,794-1.75%
31 Dec, 2135,539,8926.44%
30 Sep, 2133,388,082-0.26%
30 Jun, 2133,474,9441.93%
31 Mar, 2132,839,72320.22%
31 Dec, 2027,316,250-4.01%
30 Sep, 2028,456,174-3.10%
30 Jun, 2029,365,1831.43%
31 Mar, 2028,952,044-3.61%
31 Dec, 1930,036,7332.72%
30 Sep, 1929,240,511-1.09%
30 Jun, 1929,563,128-1.95%
31 Mar, 1930,151,5860.70%
31 Dec, 1829,941,5474.79%
30 Sep, 1828,571,9009.21%
30 Jun, 1826,162,97216.90%
31 Mar, 1822,379,7463.68%
31 Dec, 1721,584,8110.85%
30 Sep, 1721,402,133-5.53%
30 Jun, 1722,655,8378.94%
31 Mar, 1720,797,18513.64%
31 Dec, 1618,300,1998.04%
30 Sep, 1616,939,021-6.91%
30 Jun, 1618,197,1649.44%
31 Mar, 1616,627,91010.55%
31 Dec, 1515,041,0485.14%
30 Sep, 1514,305,851-

REGENXBIO (RGNX) has 9.30M shares outstanding as of 30 Jun 24, down -78.04% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2420.34%0.22%
31 Mar, 2496.84%1.29%
31 Dec, 2386.71%1.21%
30 Sep, 2384.75%1.18%
30 Jun, 2384.78%1.17%
31 Mar, 2385.27%1.26%
31 Dec, 2282.34%1.25%
30 Sep, 2281.04%1.15%
30 Jun, 2284.01%1.27%
31 Mar, 2281.31%1.18%
31 Dec, 2183.09%1.35%
30 Sep, 2178.32%1.26%
30 Jun, 2178.75%1.28%
31 Mar, 2178.53%1.47%
31 Dec, 2073.00%1.26%
30 Sep, 2076.20%1.23%
30 Jun, 2078.82%1.29%
31 Mar, 2078.03%1.18%
31 Dec, 1981.39%1.29%
30 Sep, 1979.43%1.22%
30 Jun, 1980.62%1.17%
31 Mar, 1982.91%1.20%
31 Dec, 1883.28%1.18%
30 Sep, 1884.06%1.26%
30 Jun, 1881.55%1.63%
31 Mar, 1870.75%1.36%
31 Dec, 1772.24%1.51%
30 Sep, 1769.17%1.27%
30 Jun, 1773.89%1.22%
31 Mar, 1777.97%1.63%
31 Dec, 1669.12%1.69%
30 Sep, 1664.00%1.34%
30 Jun, 1669.03%1.73%
31 Mar, 1663.16%1.93%
31 Dec, 1557.16%1.93%
30 Sep, 1554.37%-

As of 30 Jun 24, REGENXBIO is held by 20.34% institutional shareholders, representing a 0.22% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2443-58.25%
31 Mar, 2410325.61%
31 Dec, 23827.89%
30 Sep, 2376-2.56%
30 Jun, 2378-
31 Mar, 2378-13.33%
31 Dec, 2290-3.23%
30 Sep, 229319.23%
30 Jun, 2278-17.02%
31 Mar, 22944.44%
31 Dec, 2190-6.25%
30 Sep, 219612.94%
30 Jun, 2185-27.97%
31 Mar, 2111832.58%
31 Dec, 208934.85%
30 Sep, 2066-33.33%
30 Jun, 209933.78%
31 Mar, 2074-26.00%
31 Dec, 1910012.36%
30 Sep, 19891.14%
30 Jun, 1988-35.77%
31 Mar, 1913725.69%
31 Dec, 18109-19.85%
30 Sep, 181360.74%
30 Jun, 1813590.14%
31 Mar, 187122.41%
31 Dec, 17581.75%
30 Sep, 1757-5.00%
30 Jun, 17609.09%
31 Mar, 175512.24%
31 Dec, 164919.51%
30 Sep, 1641-14.58%
30 Jun, 164841.18%
31 Mar, 1634-20.93%
31 Dec, 1543-10.42%
30 Sep, 1548-

43 institutional shareholders have increased their position in RGNX stock as of 30 Jun 24 compared to 103 in the previous quarter (a -58.25% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2424-53.85%
31 Mar, 2452-10.34%
31 Dec, 235813.73%
30 Sep, 2351-12.07%
30 Jun, 2358-12.12%
31 Mar, 23664.76%
31 Dec, 22636.78%
30 Sep, 22595.36%
30 Jun, 2256-5.08%
31 Mar, 225922.92%
31 Dec, 2148-12.73%
30 Sep, 21551.85%
30 Jun, 215454.29%
31 Mar, 2135-43.55%
31 Dec, 2062-6.06%
30 Sep, 206629.41%
30 Jun, 2051-13.56%
31 Mar, 205913.46%
31 Dec, 1952-3.70%
30 Sep, 1954-14.29%
30 Jun, 196326.00%
31 Mar, 1950-
31 Dec, 1850-3.85%
30 Sep, 185262.50%
30 Jun, 1832-3.03%
31 Mar, 1833-2.94%
31 Dec, 173470.00%
30 Sep, 17205.26%
30 Jun, 1719-9.52%
31 Mar, 1721-16.00%
31 Dec, 162519.05%
30 Sep, 162161.54%
30 Jun, 1613-7.14%
31 Mar, 161416.67%
31 Dec, 1512-
30 Sep, 15--

24 institutional shareholders have reduced their position in RGNX stock as of 30 Jun 24 compared to 52 in the previous quarter (a -53.85% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2486-55.21%9,301,065-78.04%20.34%0.22%43-58.25%24-53.85%
31 Mar, 2419210.98%42,349,93811.14%96.84%1.29%10325.61%52-10.34%
31 Dec, 231736.79%38,105,9423.29%86.71%1.21%827.89%5813.73%
30 Sep, 23162-5.81%36,891,9200.15%84.75%1.18%76-2.56%51-12.07%
30 Jun, 23172-2.27%36,837,255-0.58%84.78%1.17%78-58-12.12%
31 Mar, 23176-4.35%37,051,8143.93%85.27%1.26%78-13.33%664.76%
31 Dec, 22184-0.54%35,651,1961.71%82.34%1.25%90-3.23%636.78%
30 Sep, 2218510.12%35,050,281-3.23%81.04%1.15%9319.23%595.36%
30 Jun, 22168-12.04%36,218,7113.72%84.01%1.27%78-17.02%56-5.08%
31 Mar, 221917.30%34,918,794-1.75%81.31%1.18%944.44%5922.92%
31 Dec, 21178-6.81%35,539,8926.44%83.09%1.35%90-6.25%48-12.73%
30 Sep, 211916.70%33,388,082-0.26%78.32%1.26%9612.94%551.85%
30 Jun, 21179-6.28%33,474,9441.93%78.75%1.28%85-27.97%5454.29%
31 Mar, 21191-1.55%32,839,72320.22%78.53%1.47%11832.58%35-43.55%
31 Dec, 2019414.79%27,316,250-4.01%73.00%1.26%8934.85%62-6.06%
30 Sep, 20169-8.15%28,456,174-3.10%76.20%1.23%66-33.33%6629.41%
30 Jun, 201845.75%29,365,1831.43%78.82%1.29%9933.78%51-13.56%
31 Mar, 20174-9.84%28,952,044-3.61%78.03%1.18%74-26.00%5913.46%
31 Dec, 1919310.29%30,036,7332.72%81.39%1.29%10012.36%52-3.70%
30 Sep, 19175-9.79%29,240,511-1.09%79.43%1.22%891.14%54-14.29%
30 Jun, 19194-10.60%29,563,128-1.95%80.62%1.17%88-35.77%6326.00%
31 Mar, 1921714.21%30,151,5860.70%82.91%1.20%13725.69%50-
31 Dec, 18190-10.38%29,941,5474.79%83.28%1.18%109-19.85%50-3.85%
30 Sep, 1821213.37%28,571,9009.21%84.06%1.26%1360.74%5262.50%
30 Jun, 1818746.09%26,162,97216.90%81.55%1.63%13590.14%32-3.03%
31 Mar, 1812814.29%22,379,7463.68%70.75%1.36%7122.41%33-2.94%
31 Dec, 1711220.43%21,584,8110.85%72.24%1.51%581.75%3470.00%
30 Sep, 17935.68%21,402,133-5.53%69.17%1.27%57-5.00%205.26%
30 Jun, 17882.33%22,655,8378.94%73.89%1.22%609.09%19-9.52%
31 Mar, 178610.26%20,797,18513.64%77.97%1.63%5512.24%21-16.00%
31 Dec, 16789.86%18,300,1998.04%69.12%1.69%4919.51%2519.05%
30 Sep, 16711.43%16,939,021-6.91%64.00%1.34%41-14.58%2161.54%
30 Jun, 167011.11%18,197,1649.44%69.03%1.73%4841.18%13-7.14%
31 Mar, 1663-5.97%16,627,91010.55%63.16%1.93%34-20.93%1416.67%
31 Dec, 156739.58%15,041,0485.14%57.16%1.93%43-10.42%12-
30 Sep, 1548-14,305,851-54.37%-48---

REGENXBIO Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell9,600$13.45$129.12K11,786
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell400$14.59$5.83K11,386
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell100$15.00$1.50K11,286
Aug 05, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell100$15.00$1.50K170,037
Jul 30, 2024KARABELAS ARGERIS Ndirector-S-SaleSell11,000$15.04$165.50K11,286
Jul 30, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell9,648$15.04$145.11K170,137

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024Mills Kenneth T.director-M-ExemptSell36,316$0.85$30.87K-
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell10,000$3.76$37.60K20,000
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell9,600$13.45$129.12K11,786
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell400$14.59$5.83K11,386
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell100$15.00$1.50K11,286
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell100$12.74$1.27K1,400
Aug 05, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell100$15.00$1.50K170,037
Jul 30, 2024KARABELAS ARGERIS Ndirector-S-SaleSell11,000$15.04$165.50K11,286
Jul 30, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell11,000$12.74$140.14K1,500
Jul 30, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell9,648$15.04$145.11K170,137

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 12, 2024Mills Kenneth T.director-M-ExemptBuy36,316$0.85$30.87K444,351
Aug 12, 2024Mills Kenneth T.director-M-ExemptSell36,316$0.85$30.87K-
Aug 05, 2024PAKOLA STEVEofficer Chief Medical OfficerA-AwardBuy58,386--165,578
Aug 05, 2024Christmas Patrick J.officer Chief Legal OfficerA-AwardBuy56,446--172,205
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptBuy100$12.74$1.27K21,386
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptBuy10,000$3.76$37.60K21,286
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell10,000$3.76$37.60K20,000
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell9,600$13.45$129.12K11,786
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell400$14.59$5.83K11,386
Aug 05, 2024KARABELAS ARGERIS Ndirector-S-SaleSell100$15.00$1.50K11,286
Aug 05, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell100$12.74$1.27K1,400
Aug 05, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell100$15.00$1.50K170,037
Aug 05, 2024Danos Olivierofficer Chief Scientific OfficerA-AwardBuy58,867--185,083
Aug 05, 2024Danos Olivierofficer Chief Scientific OfficerA-AwardBuy1,363$9.95$13.56K126,216
Jul 30, 2024KARABELAS ARGERIS Ndirector-M-ExemptBuy11,000$12.74$140.14K22,286
Jul 30, 2024KARABELAS ARGERIS Ndirector-S-SaleSell11,000$15.04$165.50K11,286
Jul 30, 2024KARABELAS ARGERIS Ndirector-M-ExemptSell11,000$12.74$140.14K1,500
Jul 30, 2024Simpson Currandirector, officer Chief Executive OfficerS-SaleSell9,648$15.04$145.11K170,137
Jul 26, 2024Mills Kenneth T.director-M-ExemptBuy15,369$3.76$57.79K423,404
Jul 26, 2024Mills Kenneth T.director-M-ExemptBuy12,221$3.76$45.95K420,256

The last insider sell of REGENXBIO's stock was made by Mills Kenneth T. on Aug 12 2024, selling 36,316 shares at $0.85 per share (valued at $30.87K).

REGENXBIO Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202481361.54%
Q2 2024184450.00%
Q1 20241717100.00%
Q4 20232366.67%
Q2 20231811800.00%
Q1 2023127171.43%
Q3 2022-6-
Q2 202221--
Q1 2022137185.71%
Q4 20212633.33%
Q3 20217977.78%
Q2 2021104250.00%
Q1 2021263868.42%
Q4 202041330.77%
Q3 20203475.00%
Q2 2020128150.00%
Q1 2020243372.73%
Q4 20191250.00%
Q3 201961540.00%
Q2 2019182864.29%

8 total buy trades, and 13 total sell trades (buy/sell ratio of 0.62%) were made by REGENXBIO's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-7-
Q2 2024-2-
Q1 2024-6-
Q4 2023-1-
Q2 2023---
Q1 2023-1-
Q3 2022-6-
Q2 2022---
Q1 2022-1-
Q4 2021-4-
Q3 2021-4-
Q2 2021-2-
Q1 2021-24-
Q4 2020-9-
Q3 2020-1-
Q2 2020-4-
Q1 2020-15-
Q4 2019-2-
Q3 2019-9-
Q2 2019-20-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of REGENXBIO's stocks.

REGENXBIO Peer Ownership


TickerCompany
PLRXPliant Therapeutics, Inc.
FDMT4D Molecular Therapeutics, Inc.
RVMDRevolution Medicines, Inc. Warrant
DAWNDay One Biopharmaceuticals, Inc.
RCKTRocket Pharmaceuticals, Inc.
STOKStoke Therapeutics, Inc.
IMCRImmunocore Holdings plc
RNAAvidity Biosciences, Inc.
REPLReplimune Group, Inc.
LIANLianBio
PASGPassage Bio, Inc.
ANTXAN2 Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
GLUEMonte Rosa Therapeutics, Inc.
KZRKezar Life Sciences, Inc.
PTGXProtagonist Therapeutics, Inc.
QUREuniQure N.V.
MIRMMirum Pharmaceuticals, Inc.

RGNX Ownership FAQ


REGENXBIO is owned by institutional shareholders (20.34%), insiders (7.41%), and public (72.25%). The largest institutional shareholder of REGENXBIO is BLACKROCK INC. (18.83% of total shares) and the top mutual fund owner is SPARROW FUNDS (2.16% of total shares).

REGENXBIO's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, REDMILE GROUP, LLC, JPMORGAN CHASE & CO, and STATE STREET CORP. The top five shareholders own together 52.87% of the company's share outstanding.

As of Jun 2024, there are 86 institutional shareholders of REGENXBIO.

BLACKROCK INC owns 8.61M shares of REGENXBIO, representing 18.83% of the company's total shares outstanding, valued at $100.73M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 5.11M shares of REGENXBIO (RGNX), compromising 11.18% of the company, valued at $59.83M.

REDMILE GROUP, LLC is the third largest holder of REGENXBIO. The company owns 4.57M of the company's shares outstanding (worth $53.47M).